Humanizing Monoclonal Antibodies for in vivo Use

Animal Cell Biotechnology

Volumn 6, Issue , 1994, Pages 259-279

  Harris, W J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84940972919     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-092599-8.50016-X     Document Type: Chapter

References (55)

1. Ehrlich P. On immunity with special reference to cell life. Proc. R. Soc. Ser. B. 1900, 9:112-121.
2. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:52-53.
3. Imbach P. "Immunotherapy with Intravenous Immunoglobulins" 1991, Academic Press, London.
4. Larrick J.W., Fry K.E. Recombinant antibodies. Human Antibody Hybridomas 1991, 2:172-189.
5. Borrebaek C.K., Larrick J.W. "Therapeutic Monoclonal Antibodies" 1990, Stockton Press, New York.
6. Zuckier L.S., Rodriguez L.D., Scharff M.D. Immunologic and pharmacologic concepts of monoclonal antibodies. Semin. Nucl. Med. 1989, 19:166-186.
7. Winter G., Milstein C. Man-made antibodies. Nature 1991, 349:293-299.
8. James K. "Animal Cell Biotechnology" 1990, 4:205-255. Academic Press, London. R.E. Spier, J.B. Griffiths (Eds.).
9. Clark S.A. "Animal Cell Biotechnology" 1990, 4:318-337. Academic Press, London. R.E. Spier, J.B. Griffiths (Eds.).
10. Morrison S.L., Johnson M.J., Herzenberg L.A., Oi V.T. Chimaeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. U.S.A. 1984, 82:6851-6855.
11. Adair J. Engineering antibodies for therapy. Immunol. Rev. 1992, 130:5-40.
12. Verhoeyen M., Milstein C., Winter G. Reshaping human antibodies: grafting an antilysozyme activity. Science 1988, 239:1098-1104.
13. Gussow D., Seeman G. Humanisation of monoclonal antibodies. Methods Enzymol. 1991, 203:99-121.
14. Orlandi R., Gussow D.H., Jones P.T., Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A 1989, 86:3833-3837.
15. Tarran Jones S., Bendig M.M. Rapid PCR cloning of full length mouse immunoglobulin variable regions. Biotechnology 1991, 9:88-89.
16. Sastry L., Alting-Mees W.D., Huse J.M., Short J.M., Sorge J.A., Hay B.N., Janda K.D., Benkovic S.J., Lerner R.A. Cloning of the immunoglobulin repertoire in E.coli for generation of monoclonal catalytic antibodies: Construction of a heavy chain variable region-specific cDNA library. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:5728-5732.
17. Sambrook J., Fritsch E.F., Maniatis T. "Molecular Cloning - A Laboratory Manual" 1989, 2:13.1-13.104. Cold Spring Harbor Laboratory Press, New York. 2nd edn.
18. Kabat E.A., Lu T.T., Reid-Miller M., Perry H.M., Gottesman K.S. "Sequences of Proteins of Immunological Interest" 1987, United States Department of Health and Human Services, Washington, DC. 4th edn.
19. Nakamaya K., Eckstein F. Inhibition of restriction endonuclease Neil cleavage by phosphothiorate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Res. 1986, 14:9679-9698.
20. Clackson T., Winter G. "Sticky feet"-directed mutagenesis and its application to swapping antibody domains. Nucleic Acids Res. 1989, 17:10163-10171.
21. Boshart M., Weber F., Jahan G., Dorsch-Hasler K., Fleckenstein B., Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985, 41:521-530.
22. Bebbington R.B. Expression of antibody genes in nonlymphoid mammalian cells. Methods: Companion Methods Enzymol. 1991, 2:136-145.
23. Whittle A., Adair J., Lloyd C., Jenkins L., Devine J., Schlom J., Raubitschek A., Colcher D., Bodmer M. Expression in cos cells of a mouse/human chimaeric B72.3 antibody. Protein Eng. 1987, 1:499-505.
24. Cockett M.I., Bebbington C.R., Yarrantion G.T. The use of engineered EIA genes to transactivate the HCMV-MIE promoter in permanent CHO cell lines. Nucleic Acids Res. 1991, 19:319-325.
25. Page M.J., Sydenham M.A. High level expression of the humanised monoclonal antibody campath-IH in chinese hampster ovary cells. Biotechnology 1991, 9:64-68.
26. Cockett M.I., Bebbington C.R., Yarrantoin G.T. High-level expression of tissue inhibitor of metalloproteinases in chinese hamster ovary cells using glutamine synthetase gene amplification. Biotechnology 1990, 8:662-667.
27. Bebbington C.R., Renner G., Thompson S., King D., Abrams D., Yarrantoin G.T. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 1992, 10:169-195.
28. Chothia C., Lesk A.M. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 1987, 196:901-917.
29. Chothia C., Lesk A.M., Tramontano A., Cevitt M., Smith-Gill S.J., Air G., Sheffiff S., Padlan E.A., Davies D., Tulip L.R., Colman P.M., Spinelli S., Alzari P.M., Poljak R.J. Conformations of immunoglobulin hypervariable regions. Nature 1989, 342:877-883.
30. Padlan E.A. A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties. Mol. Immunol. 1991, 28:489-498.
31. Foote J., Winter G. Antibody framework residues affecting the conformation of hypervariable loops. J. Mol. Biol. 1992, 224:487-499.
32. Gorman S.D., Clark M.R. Humanisation of monoclonal antibodies for therapy. Sem. Immunol. 1990, 2:457-466.
33. Queen C., Schneider W.P., Selick H.E., Payne P.W., Landofi N.F., Duncan J.F., Aldalovic N.M., Levitt M., Junghans R.P., Waldmann T.A. A humanised antibody that binds to the interleukin-2 receptor. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:10029-10033.
34. Daugherty B.C., Demartino J.A., Law M.F., Kawka D.W., Singer I.T., Mark G.E. Polymerase chain reaction facilitates cloning, CDR-grafting, and rapid expression of a murine monoclonal antibody against CD18. Nucleic Acids Res. 1991, 19:2471-2476.
35. Reichmann N.L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature 1988, 332:323-327.
36. Verhoeyen M., Broderick L., Eida S., Badley A. "Monoclonal Antibodies. Applications in Oncology" 1991, 37-43. Chapman & Hall, London. A.A. Epenetos (Ed.).
37. Bosslet K., Czech J., Lorenz P., Sedlacek H.H., Schuermann M., Seeman G. Molecular and functional characterisation of a fusion protein suited for tumour-specific pro-drugs activation. Br. J. Cancer 1992, 65:234-238.
38. Woodle E.S., Thistlewaite J.R., Jolliffe L.K., Zivia R.A., Collins A., Adair J., Bodmer M., Athwal D., Alegre M.-L., Bluestone J.A. Humanised OKT-3 antibodies: successful transfer of immune modulating properties and idiotype expression. J. Immunol. 1992, 148:2756-2763.
39. Gorman S.D., Clark M.R., Routledge E.G., Cubbold S.P., Waldmann H. Reshaping a therapeutic CD4 antibody. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:4181-4185.
40. Co M., Deschamps M., Whitley R.J., Owen C. Humanised antibodies for antiviral therapy. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:2869-2873.
41. Co M., Avdalovic N.M., Caron P.C., Avdalovic M.V., Scheinberg D.A., Owen C. Chimaeric and humanised antibodies with specificity for the CD33 antigen. J. Immunol. 1992, 148:1149-1154.
42. Brown P.S., Parenteau G.L., Dirbas F.M., Garsia R.J., Goldman C.K., Bukowski M.A., Junghans R.P., Queen C., Hakimi J., Benjamin W.R., Clark R.E., Waldmann T.A. Anti-Tac-H. A humanised antibody to the interleukin-2 receptor. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:2663-2667.
43. Maeda H., Matsushita S., Eda Y., Kimachi K., Tokiyoshi S., Bendig M.M. Construction of reshaped human antibodies with HIV neutralising activity. Human Antibody Hybridomas 1991, 2:124-134.
44. Kettleborough C.A., Saldanha J., Heath V.J., Morrison C., Bendig M.M. Humanisation of a mouse monoclonal antibody by CDR grafting. The importance of framework residues on loop conformation. Protein Eng. 1991, 4:773-783.
45. Tempest P.R., Breamer P., Lambert M., Taylor G., Furze J., Carr F.J., Harris W.J. Reshaping a human monoclonal antibody to inhibit respiratory syncytial virus infection. in vivo. Biotechnology 1991, 9:266-271.
46. Harris W.J., Tempest P.R. Reshaping of human antibodies for the treatment of infectious diseases. J. Cell Biochem. 1991, 15E:136.
47. Jones P.T., Dear P.H., Foote J., Neuberger M.S., Winter G. Replacing the complementary determining regions in a human antibody with those from a mouse. Nature 1986, 321:522-525.
48. HER-2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:4285-4289.
49. Routledge E.G., Lloyd I., Gorman S.D., Clark M., Waldmann H. A humanised monovalent CD3 antibody which can activate homologous complement. Eur. J. Immunol. 1991, 21:2717-2725.
50. Gorman S.D., Clark M.R., Routledge E.G., Cobbald S.P., Waldmann H. Reshaping a therapeutic CD4 antibody. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:4181-4185.
51. Armour K.L., Harris W.J., Gani M.M., Tempest P.R. "European Biotechnology Today: The Impact of Basic Sciences on Diagnosis and Therapy" 1992, 169-176. Intercept, Andover.
52. Ehrlich P.H., Ostberg L. "Therapeutic Monoclonal Antibodies" 1990, 209-222. Stockton Press, New York. C.K. Borrebaeck, J.W. Larrick (Eds.).
53. Riechmann L., Foote J., Winter G. Expression of an antibody Fv fragment in myeloma cells. J. Mol. Biol. 1988, 203:825-828.
54. Takahashi N., Ueda S., Obata M., Nikaido T., Nakai S., Honjo T. Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell 1982, 29:671-679.
55. Hieter P.A., Max E.E., Seidmann J.G., Maizel J.V., Leder P. Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell 1980, 22:197-207.